These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14732812)

  • 1. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms.
    Kooman JP; van der Sande FM; Leunissen KM
    Blood Purif; 2004; 22(1):55-9. PubMed ID: 14732812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt and hypertension in end-stage renal disease.
    Kooman JP; Leunissen KM; Luik AJ
    Blood Purif; 1998; 16(6):301-11. PubMed ID: 10343076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships among the renin-angiotensin system, sympathetic nervous system and atrial natriuretic peptide in end-stage renal failure.
    Nakajima S; Suzuki H; Kageyama Y; Ogata Y; Saruta T
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):305-11. PubMed ID: 2141372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure and heart rate variability in patients on conventional or sodium-profiling hemodialysis.
    Rubinger D; Backenroth R; Pollak A; Sapoznikov D
    Ren Fail; 2008; 30(3):277-86. PubMed ID: 18350447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Various neurohumoral aspects of hemodynamic changes in patients with hypertension after correction of electrolyte disorders].
    Isazade GM; Gadzhiev RF; Bakhshaliev AB
    Sov Med; 1991; (8):13-6. PubMed ID: 1763349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume control in peritoneal dialysis patients: role of new dialysis solutions.
    Lameire N
    Blood Purif; 2004; 22(1):44-54. PubMed ID: 14732811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension in chronic kidney failure: a volume-dependent pathology or a disease due to malnutrition?].
    Iannetti E; Carpinteri G; Trovato GM
    G Ital Cardiol; 1999 Mar; 29(3):284-90. PubMed ID: 10231674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mildly increasing dialysis sodium removal on renin and sympathetic system in hemodialysis patients.
    Shen Y; Sun F; Liu J; Ma L; Huang J; Zhou Y; Liu W
    Chin Med J (Engl); 2014; 127(14):2628-31. PubMed ID: 25043079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual renal function and volume control in peritoneal dialysis patients.
    Cheng LT; Chen W; Tang W; Wang T
    Nephron Clin Pract; 2006; 104(1):c47-54. PubMed ID: 16741370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor.
    Graves SW; Glatter KA; Lazarus JM; Williams GH; Hollenberg NK
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S54-7. PubMed ID: 7508029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in end-stage renal failure: role of sympathetic nervous system, sodium balance and renal pressor system.
    Zucchelli P; Zuccala A; Sturani A; Degli Esposti E; Ligabue A; Santoro A; Gattiani A; Chiarini C
    Life Support Syst; 1983; 1(2):101-11. PubMed ID: 6381895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and neurogenic adaptations to reduced dietary sodium in the SHR model of hypertension.
    Ely DL; Paradise NF; Folkow B
    Klin Wochenschr; 1991; 69 Suppl 25():58-72. PubMed ID: 1656136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.
    Blankestijn PJ; Ligtenberg G
    Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and hypertension.
    Williams GH
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():31-40. PubMed ID: 6754184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.